Serum levels and in situ expression of TNF-alpha and TNF-alpha binding proteins in inflammatory liver diseases

被引:42
|
作者
Spengler, U
Zachoval, R
Gallati, H
Jung, MC
Hoffmann, R
Riethmuller, G
Pape, G
机构
[1] UNIV MUNICH, KLINIKUM GROSSHADERN, DEPT INTERNAL MED 2, D-81377 MUNICH, GERMANY
[2] UNIV MUNICH, INST IMMUNOL, D-80336 MUNICH, GERMANY
[3] F HOFFMANN LA ROCHE & CO LTD, CENT RES UNITS, CH-4002 BASEL, SWITZERLAND
关键词
tumour necrosis factor; tumour necrosis factor binding protein; interferon therapy; viral hepatitis; alcoholic hepatitis;
D O I
10.1006/cyto.1996.0115
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cells respond to tumour necrosis factor-alpha (TNF-alpha) via binding to 75-kDa (type A) and 55-kDa (type B) receptors which have different intracellular signalling pathways and can also circulate as soluble molecules. Both receptors are co-expressed in many tissues, but their relative contributions to cellular TNF responses is for most situations unknown. In patients with viral and non-viral inflammatory liver diseases serum TNF-alpha was determined by an immunoenzymetric assay and soluble type A and B TNF receptors (TNF-alpha r) by enzyme-linked immunological and biological assays (ELIBA). In addition, cellular expression of TNF and its binding proteins were studied in liver biopsies by an indirect immunoperoxidase technique. Secretion of TNF-alpha and upregulation of TNF-alpha r-A were particularly prominent in viral hepatitis. Strong TNF-alpha in-situ production by mononuclear cells could be demonstrated in liver biopsies from patients with acute viral hepatitis. However, TNF-alpha r-A was detected only on hepatocytes. Serum TNF-alpha r-A was elevated two-fold in relative abundance over TNF-alpha r-B and was correlated to serum TNF-alpha (r = 0.6464, P < 0.0001). Soluble TNF-alpha r levels normalized, when the viral hepatitis was cleared, and successful therapy of hepatitis B was associated with a temporary rise of TNF-alpha r-A during the initial flare of aminotransferases. Patients with alcoholic hepatitis had also evidence of TNF-alpha activation but clearly differed from patients with viral induced liver diseases: Soluble TNF-alpha r-A and TNF-alpha r-B were highly elevated in equal proportions. In situ analysis in liver biopsies revealed a distinctive pattern of TNF-alpha r expression with strong cytoplasmic staining for both TNF-alpha r-A and B on scattered hepatocytes in addition to infiltrating mononuclear cells. The data propose that TNF release during antiviral immune responses is predominantly associated with TNF-alpha r-A upregulation and shedding, whereas upregulation and shedding of TNF-alpha r-B is more prominent in alcoholic hepatitis. As cytotoxicity and apoptosis by TNF are mediated mainly via TNF-alpha r-B, our results are consistent with more severe TNF-alpha induced liver damage in alcoholic hepatitis as compared to viral hepatitis. (C) 1996 Academic Press Limited.
引用
收藏
页码:864 / 872
页数:9
相关论文
共 50 条
  • [21] SERUM TNF-ALPHA INHIBITOR IN MOUSE TYPHOID
    MASTROENI, P
    VILLARREAL, B
    DEHORMAECHE, RD
    HORMAECHE, CE
    MICROBIAL PATHOGENESIS, 1992, 12 (05) : 343 - 349
  • [22] EFFECT OF TNF-ALPHA BLOCKADE ON THE MINERAL METABOLISM IN CHRONIC INFLAMMATORY DISEASES
    Malouf Sierras, J.
    Aguilar-Del-Rey, I.
    Garcia-Portales, R.
    de Haro Liger, M.
    Rodriguez Andreu, J.
    Casals Sanchez, J. L.
    Perez Gonzalez, R.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S754 - S755
  • [23] PTHRP AND TNF-ALPHA LEVELS IN TUMORAL HYPERCALCEMIA
    HURTADO, J
    DEMIGUEL, F
    LOARTE, D
    JARAS, MJ
    MOTELLON, J
    ESBRIT, P
    DIAZ, A
    CALCIFIED TISSUE INTERNATIONAL, 1994, 54 (05) : 453 - 453
  • [24] TNF-ALPHA BIOACTIVITY: A NEW BIOMARKER OF ASPA ACTIVITY IN PATIENTS WITH TNF-ALPHA BLOCKERS
    Constant, E.
    Rinaudo-Gaujous, M.
    Amouzougan, A.
    Pallot-Prades, B.
    Collet, P.
    Thomas, T.
    Paul, S.
    Marotte, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 237 - 237
  • [25] Aspirin, TNF-alpha, NFkB, and survival in multiple myeloma: the importance of measuring TNF-alpha
    R. E. Kast
    InflammoPharmacology, 2006, 14 (5-6) : 256 - 259
  • [26] TNF-alpha expression in painful and nonpainful neuropathies
    Empl, M
    Renaud, S
    Erne, B
    Fuhr, P
    Straube, A
    Schaeren-Wiemers, N
    Steck, AJ
    NEUROLOGY, 2001, 56 (10) : 1371 - 1377
  • [27] TNF-alpha in headache patients
    Bagala, A.
    Bastone, L.
    Ferraro, T.
    Casaletto, M.
    Romeo, N.
    Di Palma, G.
    Cavalcanti, F.
    Condino, F.
    Crescibene, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 239 - 239
  • [28] Inhibitors of TNF-alpha secretion
    Immunex Corp, Seattle, United States
    Biotechnol Adv, 3-4 (781-782):
  • [29] VEGF and TNF-alpha serum levels in patients with Behcet's uveitis
    Yilmaz, OS
    Dinc, A
    Erdem, H
    Simsek, I
    Pay, S
    Pekel, A
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 323 - 323
  • [30] TNF-alpha and VEGF serum levels in patients with different subtypes of MDS
    Serafyn, N.
    Vyhovska, J.
    Danysh, O.
    Tomashevska, N.
    Masliak, Z.
    LEUKEMIA RESEARCH, 2007, 31 : S51 - S51